CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
Recruiting · NCT06482684 · Registry updated 2024-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 2 | 2024-07-01 | NCT06482684 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Christian Schmidt, MD | 1 |
| Johannes Gutenberg University Mainz | 34 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Klinikum der Universität München | Munich | Germany | 1 |
| University Hospital of Mainz | Mainz | Germany | 1 |